Among them, prognostic signatures of immune-related genes/lnRNAs25,26, epithelial-mesenchymal transition/subtype27,28, immune checkpoints/PD-L1-based signatures29, and even glioma stem cell signatures30, to predict prognosis and response to treatment are of interest. The gene discussed is CD274; the disease is glioma.